THE COA ESTERS OF 2-METHYL-BRANCHED CHAIN FATTY-ACIDS AND OF THE BILE-ACID INTERMEDIATES DIHYDROXYCOPROSTANIC AND TRIHYDROXYCOPROSTANIC ACIDS ARE OXIDIZED BY ONE SINGLE PEROXISOMAL BRANCHED-CHAIN ACYL-COA OXIDASE IN HUMAN LIVER AND KIDNEY
Gf. Vanhove et al., THE COA ESTERS OF 2-METHYL-BRANCHED CHAIN FATTY-ACIDS AND OF THE BILE-ACID INTERMEDIATES DIHYDROXYCOPROSTANIC AND TRIHYDROXYCOPROSTANIC ACIDS ARE OXIDIZED BY ONE SINGLE PEROXISOMAL BRANCHED-CHAIN ACYL-COA OXIDASE IN HUMAN LIVER AND KIDNEY, The Journal of biological chemistry, 268(14), 1993, pp. 335-344
Rat liver peroxisomes contain three acyl-CoA oxidases: palmitoyl-CoA o
xidase, which oxidizes the CoA esters of straight chain fatty acids an
d prostaglandins; pristanoyl-CoA oxidase, which oxidizes the CoA ester
s of 2-methyl-branched fatty acids (e.g. pristanic acid); and trihydro
xycoprostanoyl-CoA oxidase, which oxidizes the CoA esters of the bile
acid intermediates di- and trihydroxycoprostanic acids (Van Veldhoven,
P. P., Vanhove, G., Asselberghs, S., Eyssen, H. J., and Mannaerts, G.
P. (1992) J. Biol. Chem. 267, 20065-20074). In the present report we
demonstrate that human liver peroxisomes contain only two acyl-CoA oxi
dases: palmitoyl-CoA oxidase, which oxidizes the CoA esters of straigh
t chain fatty acids and prostaglandins, and a novel branched chain acy
l-CoA oxidase, which oxidizes the CoA esters of 2-methyl-branched fatt
y acids as well as those of the bile acid intermediates (which also po
ssess a 2-methyl substitution in their side chains). The branched chai
n acyl-CoA oxidase was purified to near homogeneity by means of column
chromatography. It appeared to be a 70-kDa monomeric protein that did
not cross-react with antisera raised against rat palmitoyl-CoA oxidas
e and pristanoyl-CoA oxidase. No indication was found for the presence
of a separate trihydroxycoprostanoyl-CoA oxidase in human liver. The
branched chain acyl-CoA oxidase was present also in human kidney, sugg
esting that it is expressed in other extrahepatic tissues as well. Our
results explain a number of clinical-chemical observations made in ce
rtain cases of peroxisomal beta-oxidation disorders.